Real-world Data on the Effectiveness and Safety of Ixazomib-Lenalidomide-Dexamethasone Therapy in Relapsed/refractory Multiple Myeloma Patients: a Multicenter Experience in Turkey
Journal of Chemotherapy(2023)
Key words
proteasome inhibitors,ixazomib,lenalidomide,multiple myeloma,Turkey,multicenter
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined